Company

The Silicon Review

ATESSIA, Your Guide to Efficient Regulatory Affairs in the Pharma Industry 

In the intricate and highly regulated world of pharmaceuticals and healthcare, ATESSIA stands out as a consulting firm dedicated to guiding companies through the complexities of regulatory affairs. Recognizing the critical role of compliance and patient safety, ATESSIA offers comprehensive expertise that spans scientific documentation, clinical trials, regulatory submissions, and pharmacovigilance. By ensuring seamless collaboration with regulatory authorities across multiple jurisdictions, ATESSIA helps companies achieve compliance while driving growth and maintaining a strong focus on patient welfare and product efficacy. 

Regulatory Affairs: a Growth Engine 

Regulatory affairs are far more than a checklist of tasks—they represent a strategic driver of growth and innovation within the pharmaceutical and medical device sectors. At their core, they ensure that products meet the highest safety and quality standards, from development to commercialization. This involves aligning manufacturing processes with legal requirements, maintaining ongoing communication with regulatory authorities, and managing the vast documentation required for regulatory submissions. 

Regulatory affairs also operate as a vital connector, fostering collaboration across clinical, medical, and marketing teams to ensure that every stage of product development adheres to regulatory standards. Beyond compliance, they enable strategic growth by guiding research and development efforts, supporting faster market access through regulatory frameworks, and facilitating partnerships and licensing agreements. Moreover, regulatory expertise ensures that companies can enter new markets efficiently, navigating diverse local requirements while maintaining compliance for existing products as regulations evolve. 

Balancing Regulatory Workload 

An overburdened regulatory workload can strain a company’s resources, stifling growth and innovation. ATESSIA’s solutions address this challenge by alleviating internal pressures, allowing teams to focus on core activities such as clinical trials and market strategy. 

By partnering with ATESSIA, companies gain access to a balanced approach to regulatory affairs. ATESSIA’s expertise accelerates market access by efficiently managing regulatory submissions and ensures operations remain cost-effective and controlled. As an independent consultancy, ATESSIA provides objective and unbiased advice, enabling clients to navigate the complexities of the regulatory landscape with confidence. 

What makes french Regulatory Affairs unique and how can ATESSIA Help? 

The French pharmaceutical market presents unique challenges and opportunities due to its distinct regulatory environment. Stringent requirements from the ANSM (Agence Nationale de Sécurité du Médicament et des Produits de Santé), coupled with specific laws such as the Public Health Code, create a complex framework for compliance. ATESSIA acts as a strategic partner for international companies, offering expert guidance to navigate these complexities and thrive in the French market. 

Key challenges include obtaining Exploitant status, adhering to packaging and labeling requirements, maintaining robust pharmacovigilance systems, and complying with strict advertising and anti-gift regulations. ATESSIA also supports companies in negotiating pricing and reimbursement with the HAS (Haute Autorité de Santé) and the CEPS (Comité Économique des Produits de Santé), ensuring optimal market entry strategies and compliance. 

ATESSIA’s Commitment to Customer Experience 

Led by Géraldine Baudot-Visser, ATESSIA is built on a foundation of precision, flexibility, and a deep understanding of client needs. The company prioritizes tailored solutions, crafting regulatory strategies that align with each client’s specific context, sector, and objectives. With a commitment to transparency, ATESSIA ensures clear and open communication throughout every project, empowering clients to make informed decisions confidently. 

This long-term partnership approach positions ATESSIA as more than just a regulatory consultant. By adapting to changing regulatory environments and supporting clients as they grow, ATESSIA becomes an essential ally in achieving compliance and fostering sustainable growth. 

ATESSIA transforms regulatory affairs from an operational challenge into a strategic tool for success. By providing unparalleled support and expertise, the company helps pharmaceutical businesses navigate complex landscapes, achieve compliance, and capitalize on growth opportunities. 

For more information, visit www.atessia.fr or reach out via email at hello@atessia.fr. ATESSIA’s team is ready to help optimize your regulatory affairs and support your strategic objectives. 

To read the full article on Silicon Review, click here

ATESSIA Named Among the “5 Best Pharma Consulting Companies to Watch in 2024”

We are proud to be featured in The Silicon Review, a recognition that highlights our unwavering commitment to excellence in regulatory affairs. 

In the pharmaceutical industry, regulatory compliance is more than a requirement—it is the foundation for driving innovation and safeguarding patient health. At ATESSIA, we tackle these challenges with precision and a strategic approach, helping our clients achieve their long-term goals. 

Why partner with ATESSIA? 

  • Streamlined Processes: We simplify regulatory workflows, enabling your teams to focus on innovation and clinical success. 
  • Accelerated Market Entry: With deep expertise in French regulatory requirements (Exploitant status, pricing, market authorizations), we ensure a smooth entry into the French market. 
  • Sustainable Compliance: Our tailored strategies align regulatory adherence with your budget and timeline constraints. 
  • Independent Expertise: As an autonomous consultancy, we offer objective guidance backed by in-depth knowledge of the pharmaceutical landscape. 

This achievement represents a key milestone in our mission to transform regulatory affairs into a strategic advantage for our clients. 


Let’s stay connected ! Our services

Learn more: Read the article 

Forbes BrandVoice by MédiasFrance

Forbes – ATESSIA, Life Science Advisors : The Regulatory and Pharmaceutical Affairs Consulting Firm Dedicated to the Healthcare Industry

Leveraging its expertise, ATESSIA supports a wide range of health products, with a particular focus on pharmaceuticals and medical devices. Through a tailored and rigorous approach, the firm helps its clients navigate complex regulatory landscapes, ensuring compliance and innovation in their projects.

More Human, More Agile

“I founded ATESSIA, Life Science Advisors, with the conviction that regulatory and pharmaceutical affairs consulting could be reimagined through a more human and agile lens,” explains Géraldine Baudot-Visser. Drawing on several years of experience in the pharmaceutical industry and renowned consulting firms, I recognized the opportunity to create a company that prioritizes client satisfaction and the empowerment of its experts while ensuring unwavering excellence in the pharmaceutical field.” The initial challenges naturally revolved around gaining the trust of the first clients and dismantling stereotypes about consulting. The firm needed to prove that rigor and creativity can coexist and demonstrate that a consulting firm can combine cutting-edge expertise with a bespoke approach. Striking the balance between managing a young company and delivering excellence has been a top priority since day one. For the founder, the goal was clear: to become a reference in regulatory consulting in the French and European markets within a few years, despite competition from established firms.

Tailor-Made Solutions, Continuously Enhanced

Every phase of ATESSIA’s growth has been driven by the ambition to establish itself as a leader while rallying employees around its clients’ challenges. Each step has also been an opportunity to reinvent, innovate, and grow while staying true to its values to ensure a client-centered approach. “For example,” says the founder, “our regulatory intelligence service is essential for our pharmaceutical clients, achieving a satisfaction and retention rate exceeding 90%. This success reflects our ability to provide tailored support and anticipate market changes, meeting the most demanding expectations of our partners.” This commitment to exceeding expectations relies on a team capable of anticipating, adapting, and ensuring compliance with the strictest standards. This collective dynamic keeps ATESSIA at the forefront, offering clients ever more efficient, custom-tailored solutions.

An Excellence-Driven Approach

“Our clients choose us because they seek far more than standardized solutions. At ATESSIA, we work with the precision of master artisans, designing bespoke solutions perfectly adapted to the specificities of each project in a highly regulated environment. Like the finest craftsmen of traditional expertise, we pay particular attention to ensuring impeccable quality in our services to provide reliable technical support to our clients,” shares Géraldine Baudot-Visser. This excellence-driven approach makes ATESSIA a trusted partner for its clients. The consulting firm builds strong relationships founded on attentive listening, in-depth expertise, and the ability to anticipate market changes. This proactive, personalized vision allows ATESSIA to deliver solutions that are always perfectly adapted and tailored.

“Every contribution we make to the healthcare industry, no matter how modest, has the potential to impact someone’s life somewhere. This gives profound meaning to what we do and makes every project-whether centered on pharmaceutical facilities, system quality, or innovation-much more than just a mission for us: it’s an opportunity to actively contribute to improving patients’ lives. This responsibility is a source of immense and invaluable pride,” she concludes.

https://www.forbes.fr/mediasfrance/atessia/

ATESSIA Life Science Advisors, a Catalyst for Regulatory Innovation: Collaborating with UBAQ, ATESSIA Sets a New Standard to Facilitate the Management of Regulatory Challenges in the Health Sector

An alliance capable of moving mountains.

ATESSIA and UBAQ jointly pave the way for health sector players.

The health sector, constantly evolving and in the spotlight, requires wisely chosen partnerships.

ATESSIA, a consulting and expertise firm in regulatory and pharmaceutical affairs, and UBAQ, a recognized expert in SaaS solutions for Health Tech, naturally meet at the crossroads of their paths.

Their collaboration aims to simplify and strengthen the regulatory management of health industries, each contributing their expertise: ATESSIA with its deep knowledge of the regulatory field, distinctive know-how, and disruptive approach to consulting, and UBAQ with its sharp technological skills and fresh perspective on sector challenges.

Together, they offer a value proposition that combines innovation, expertise, and accessibility.

With this partnership, ATESSIA offers tailored support, deeply focused on quality customer experience, aiming to meet diverse needs and expectations at every interaction level.

“We were looking for a technical solution with an innovative approach to offer our clients. Having been in contact with UBAQ for several years, we now fully trust them and share the same values and ambitions: to support the Health Industries in their regulatory issues, always placing patients at the heart of our solutions.”

Géraldine BAUDOT-VISSER, Doctor of Pharmacy, founder of ATESSIA, and AMARYLYS.


A Tailored Partnership for the Health Industries

Always seeking to add value for health industry players, ATESSIA has teamed up with UBAQ to offer tailored support. This collaboration revolves around implementing an innovative technical tool designed to ease the daily life of health industry professionals. Indeed,

UBAQ aims to provide its clients with regulatory support that goes beyond its SaaS solution, choosing to partner with one of the most renowned firms in this field.

Both companies share a key priority: placing the customer, their experience, and satisfaction at the heart of each solution.

In addition to tool implementation, ATESSIA offers 360° support, covering all business and regulatory issues health industries may face.

This partnership provides an integrated solution, combining ATESSIA’s sharp expertise with an intuitive digital tool to ensure optimal regulatory compliance.

“Partnering with a regulatory affairs firm was obvious for us and is in line with the continuous support we offer our clients. ATESSIA breaks the mold and stands out with a very flexible and innovative approach: this is exactly what we were looking for.”

François CANCELLONI, General Manager and co-founder of UBAQ.


ATESSIA Life Science Advisors: The Strategic Partner in Pharmaceutical Regulatory Navigation

Founded in 2017 by Géraldine BAUDOT-VISSER, Doctor of Pharmacy, ATESSIA Life Science Advisors is an essential player in guiding health industries through regulatory landscape challenges.

With a team of experts and a client-centered approach, ATESSIA ensures compliance and relevance through personalized technical and strategic development support and health product commercialization.

ATESSIA positions itself as a market leader, with its insightful regulatory monitoring service, ATESSIA INTELLIGENCE, handling French and European regulatory subtleties.

ATESSIA’s renown highlights its expertise and commitment to assisting clients in successfully navigating the rigorous and complex world of regulatory and pharmaceutical affairs.


Key Points:

  • Expertise in 6 main areas: Pharmaceutical Affairs, Regulatory Affairs, Quality System Management, Health Product Promotion, Pharmacovigilance, Medical Devices, Regulatory Monitoring.
  • 126 companies subscribed to the regulatory monitoring tool, ATESSIA INTELLIGENCE.
  • Extended presence in Paris, Lyon, Luxembourg, Nice, Bordeaux, Lille, Auxerre, Orléans, and other locations.
  • 98% retention and satisfaction rate, according to the ISO indicator.

UBAQ, European Leader in Health Tech

Founded in 2023 from the merger of Qairn and Clardian (formerly BMI System), UBAQ supports the digital transformation of health industries with a suite of SaaS software.

These software solutions help dematerialize and simplify the application of the particularly strict and constantly evolving regulatory framework. UBAQ offers two solutions:

  • UBAQ DocPromo, which aims to comply with promotional documents.
  • NAYACT Transparency by UBAQ, focusing on the Law of Benefits Framework and transparency of interest links.

Life Sciences Review: Atessia: Tailor-made solutions for Pharmaceutical Regulatory Changes 🇬🇧

We are happy to share that ATESSIA, Life Science Advisors was selected by Life Sciences Review among the top 10 regulatory consulting firms in Europe for 2022.


Excitement, of course, is part of the deal, but so are the will to keep on giving our best and moving forward.


This success is the direct result of hard work, dedication and commitment of a team that shares the same vision, and seeks innovative solutions to complex challenges.


We believe that the best is yet to come.


➡️ Atessia – Regulatory Services Europe Solutions/Service Company

Atessia celebrates its 5th birthday!

Founded in 2017 by Géraldine Baudot-Visser, Atessia, Life Science Advisors is celebrating its 5th anniversary this year!

5 years during which our team of expert consultants has grown
5 years of tailor-made support to our 120 long-term clients
5 years of rewarding expertise working on complex and innovative projects
5 years that are the first of a long adventure!

Thank you all for your daily confidence ✨

Double certification: ISO 9001 & Qualiopi

Géraldine BAUDOT-VISSER and her team are proud to announce that ATESSIA is now certified by AFNOR according to two Quality standards: ISO 9001 for our expertise and consulting activity and Qualiopi for our in-company training offer.

Since its creation, the Customer Experience and the Quality of our services, thanks to defined processes, are at the heart of the principles cultivated within ATESSIA.

This corporate commitment aims to stimulate our continuous improvement approach with the aim of maintaining your satisfaction on a daily basis while remaining the agile and flexible consulting company that you know.

We keep our quality of listening, our proximity and our availability for your teams.

  • Our “ISO 9001” certification demonstrates ATESSIA’s ability to consistently provide a product or service that meets the requirements of its clients and the applicable legal and regulatory requirements, and our commitment to increasing client satisfaction.
  • Our “Qualiopi” certification attests to the quality of the process implemented by ATESSIA in the development and delivery of its professional training courses, which contribute to the development of skills and allow companies to access public and mutualised funds for their financing.

Happy New Year 2022

✨ Let’s go 2022! 🍾 The Atessia team, wishes you and your loved ones happiness, health and success for this new year!

Welcome to François-Mayeul Boudet

Welcome to François-Mayeul Boudet in the ATESSIA, Life Science Advisors Team! He will work as a Junior Advisor in Pharmaceutical Affairs! The whole team welcomes him!